Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph R Weichselbaum

Showing results (51-60 of 364) with videos related to

Pageof 37
Sort By:
Advanced Drug Delivery Reviews|April 14, 2025
Designing live bacterial therapeutics for cancerJaehyun Lee, Sandra McClure, Ralph R Weichselbaum, et al.
Journal of the National Cancer Institute|November 11, 2017
Retuning the Radio in RadiobiologySteven J Chmura, Philip P Connell, Ralph R Weichselbaum
Angewandte Chemie (International Ed. in English)|August 15, 2024
Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer TreatmentWenyao Zhen, Tomas Germanas, Ralph R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2020
Oligometastasis: Past, Present, FutureStanley I Gutiontov, Sean P Pitroda, Ralph R Weichselbaum
Trends in Cancer|November 6, 2021
Radiotherapy and immunotherapy: open questions and future strategiesKelli B Pointer, Sean P Pitroda, Ralph R Weichselbaum
Nature Genetics|January 3, 2023
Author Correction: Tumor aneuploidy predicts survival following immunotherapy across multiple cancersLiam F Spurr, Ralph R Weichselbaum, Sean P Pitroda
Journal of Surgical Oncology|July 12, 2008
A rationale for the targeted treatment of oligometastases with radiotherapyDhara M Macdermed, Ralph R Weichselbaum, Joseph K Salama
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Enhancing radiotherapy with genetically engineered virusesSunil J Advani, Ralph R Weichselbaum, Steven J Chmura
Science Translational Medicine|February 22, 2013
New paradigms and future challenges in radiation oncology: an update of biological targets and technologyStanley L Liauw, Philip P Connell, Ralph R Weichselbaum
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 16, 2024
Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer ImmunotherapyYouyou Li, Jing Liu, Ralph R Weichselbaum, et al.
Pageof 37

Showing results (51-60 of 364) with videos related to

Sort By:
Pageof 37
Advanced Drug Delivery Reviews|April 14, 2025
Designing live bacterial therapeutics for cancerJaehyun Lee, Sandra McClure, Ralph R Weichselbaum, et al.
Journal of the National Cancer Institute|November 11, 2017
Retuning the Radio in RadiobiologySteven J Chmura, Philip P Connell, Ralph R Weichselbaum
Angewandte Chemie (International Ed. in English)|August 15, 2024
Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer TreatmentWenyao Zhen, Tomas Germanas, Ralph R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2020
Oligometastasis: Past, Present, FutureStanley I Gutiontov, Sean P Pitroda, Ralph R Weichselbaum
Trends in Cancer|November 6, 2021
Radiotherapy and immunotherapy: open questions and future strategiesKelli B Pointer, Sean P Pitroda, Ralph R Weichselbaum
Nature Genetics|January 3, 2023
Author Correction: Tumor aneuploidy predicts survival following immunotherapy across multiple cancersLiam F Spurr, Ralph R Weichselbaum, Sean P Pitroda
Journal of Surgical Oncology|July 12, 2008
A rationale for the targeted treatment of oligometastases with radiotherapyDhara M Macdermed, Ralph R Weichselbaum, Joseph K Salama
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Enhancing radiotherapy with genetically engineered virusesSunil J Advani, Ralph R Weichselbaum, Steven J Chmura
Science Translational Medicine|February 22, 2013
New paradigms and future challenges in radiation oncology: an update of biological targets and technologyStanley L Liauw, Philip P Connell, Ralph R Weichselbaum
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 16, 2024
Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer ImmunotherapyYouyou Li, Jing Liu, Ralph R Weichselbaum, et al.
Pageof 37